QuikClot® hemostatic devices are different from standard surgical gauzes and other hemostatic agents. They stop bleeding significantly faster and are more effective than standard gauzes1,2—and they are just as safe and intuitive to use.11
Trauma is a major cause of death and disability and the second most expensive healthcare problem in the United States. Approximately 40% of trauma-related deaths are due to bleeding or its consequences, establishing hemorrage as the most common cause of preventable death in trauma.9
QuikClot® devices, applied with manual pressure, promote clotting within minutes from application to help you and your team save more lives.
QuikClot® devices come in many different forms and sizes, which are adaptable to treat a broad range of bleeding situations. They are trusted and relied on by: Healthcare Professionals First Responders Law Enforcement Military
QuikClot® hemostatic devices at a glance:
Fast & Effective
Promotes clotting within minutes of application1-3,5,11
The Committee on Tactical Combat Casualty Care (CoTCCC) recommends QuikClot Combat Gauze® as the hemostatic agent of choice for compressible hemorrhage not amenable to tourniquet use6
No shellfish, human, or animal proteins
Low-to-no risk of adverse reactions8
Familiar and easy-to-use format
Conforms readily to wound site
Efficient & Valuable
Less expensive than protein-based products; may reduce the need for additional expensive treatments4
Stops bleeding faster than standard gauze1,2
QuikClot® kaolin technology accelerates the body’s natural clotting cascade2
For more than 8 years, QuikClot® hemostatic devices have been made with kaolin. Kaolin works on contact with blood to immediately initiate the clotting process by activating factor XII.4 This reaction leads to the transformation of factor XII to its activated form XIIa, which instigates the rest of the coagulation cascade.
QuikClot® hemostatic devices promote clotting within minutes1-3,5,11
Rotational Thromboelastometry (ROTEM) is used in bleeding situations to assess the viscoelastic properties of whole blood hemostasis. In vitro, ROTEM demonstrates the kinetics of clot formation associated with the interaction of enzymatic coagulation factors, fibrinogen, platelets and cellular components and is a recommended diagnostic tool for assessment and guidance when controlling bleeding. Clot Time (CT) describes the onset of clot formation (in sec), Clot Formation Time (CFT) shows clot propagation (in sec), and the alpha angle (α) is taken tangent to the clotting curve at 2mm (in degrees ᵒ).
QuikClot treated blood shows a faster CT, shorter CFT and steeper α than blood alone which indicates that the clot is activated quickly and amplifies rapidly. The greater the amplitude of the graph, the firmer the clot (A10, MCF: maximum clot firmness). As can be seen in the graph, QuikClot treated blood forms a firmer clot faster than untreated blood.
QuikClot Combat Gauze® is recommended by CoTCCC for all 5 branches of the US military6
In 2008, after extensive testing, the CoTCCC chose QuikClot Combat Gauze® as the only hemostatic dressing used by all branches of the US military for compressible hemorrhage not amenable to tourniquet use or as an adjunct to tourniquet removal if evacuation time is anticipated to be longer than 2 hours.6Today, QuikClot Combat Gauze® still remains the hemostatic device of choice by the CoTCCC. The Department of Defense is funding research to explore other applications of QuikClot® products in bleeding associated with traumatic injuries. QuikClot® dressings are credited with saving lives.